A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

ZNA Stuivenberg, Antwerp

UZ Leuven, Leuven

Oslo Universitetssykehus - Rikshospitalet, Oslo

AZ Sint-Jan Brugge, Bruges

Mount Sinai - PRIME, Lake Success

Skanes Universitetssjukhus, Lund, Lund

OSU - James Comprehensive Cancer Center, Columbus

CHU Nantes - Hotel Dieu, Nantes

Hopital Claude Huriez - CHU Lille, Lille

Washington University, St Louis

Akademiska Sjukhuset, Uppsala

Baylor University Medical Center, Dallas

Hopital Saint-Antoine, Paris

Seattle Cancer Care Alliance, Seattle

Massachusetts General Hospital, Boston